722 related articles for article (PubMed ID: 29157815)
1. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
2. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
3. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
5. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
6. Fuzheng Touxie Jiedu Huayu Decoction inhibits the MexAB-OprM efflux pump and quorum sensing-mediated biofilm formation in difficult-to-treat multidrug resistance Pseudomonas aeruginosa.
Liu T; Xu H; Huang T; Liu G; Cao H; Lin Y; Li Y; Li Y; Yao X
J Ethnopharmacol; 2024 Oct; 332():118365. PubMed ID: 38796070
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
8. Role of MexAB-OprM efflux pump in the emergence of multidrug-resistant clinical isolates of Pseudomonas aeruginosa in Mazandaran province of Iran.
Ahmadian L; Haghshenas MR; Mirzaei B; Khalili Y; Goli HR
Mol Biol Rep; 2023 Mar; 50(3):2603-2609. PubMed ID: 36626068
[TBL] [Abstract][Full Text] [Related]
9. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
10. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
[TBL] [Abstract][Full Text] [Related]
11. Effect of piperine on the inhibitory potential of MexAB-OprM efflux pump and imipenem resistance in carbapenem-resistant Pseudomonas aeruginosa.
Liu Y; Zhu R; Liu X; Li D; Guo M; Fei B; Ren Y; You X; Li Y
Microb Pathog; 2023 Dec; 185():106397. PubMed ID: 37852553
[TBL] [Abstract][Full Text] [Related]
12. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
[TBL] [Abstract][Full Text] [Related]
13. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
14. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.
Nehme D; Poole K
J Bacteriol; 2007 Sep; 189(17):6118-27. PubMed ID: 17586626
[TBL] [Abstract][Full Text] [Related]
15. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.
Maseda H; Yoneyama H; Nakae T
Antimicrob Agents Chemother; 2000 Mar; 44(3):658-64. PubMed ID: 10681335
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efflux pump inhibitors of MexAB- or MexXY-OprM in Pseudomonas aeruginosa using nucleic acid dyes.
Fujiwara M; Yamasaki S; Morita Y; Nishino K
J Infect Chemother; 2022 May; 28(5):595-601. PubMed ID: 35168878
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
18. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Suresh M; Nithya N; Jayasree PR; Vimal KP; Manish Kumar PR
World J Microbiol Biotechnol; 2018 May; 34(6):83. PubMed ID: 29846800
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.
Middlemiss JK; Poole K
J Bacteriol; 2004 Mar; 186(5):1258-69. PubMed ID: 14973037
[TBL] [Abstract][Full Text] [Related]
20. Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa.
Horna G; López M; Guerra H; Saénz Y; Ruiz J
Sci Rep; 2018 Nov; 8(1):16463. PubMed ID: 30405166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
